The Characterization of the Human Nasal Epithelial Cell Line RPMI 2650 Under Different Culture Conditions and Their Optimization for an Appropriate in vitro Nasal Model

ABSTRACT Purpose The further characterization of the cell line RPMI 2650 and the evaluation of different culture conditions for an in vitro model for nasal mucosa. Methods Cells were cultured in media MEM or A-MEM at air-liquid (A-L) or liquid-liquid (L-L) interfaces for 1 or 3 weeks. Different cryo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceutical research 2015-02, Vol.32 (2), p.665-679
Hauptverfasser: Kreft, Mateja Erdani, Jerman, Urška Dragin, Lasič, Eva, Lanišnik Rižner, Tea, Hevir-Kene, Neli, Peternel, Luka, Kristan, Katja
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 679
container_issue 2
container_start_page 665
container_title Pharmaceutical research
container_volume 32
creator Kreft, Mateja Erdani
Jerman, Urška Dragin
Lasič, Eva
Lanišnik Rižner, Tea
Hevir-Kene, Neli
Peternel, Luka
Kristan, Katja
description ABSTRACT Purpose The further characterization of the cell line RPMI 2650 and the evaluation of different culture conditions for an in vitro model for nasal mucosa. Methods Cells were cultured in media MEM or A-MEM at air-liquid (A-L) or liquid-liquid (L-L) interfaces for 1 or 3 weeks. Different cryopreservation methods and cell culture techniques were evaluated with immunolabelling of junctional proteins, ultrastructural analysis using electron microscopy, transepithelial electrical resistance (TEER) measurements, permeation studies with dextran and jacalin, and gene expression profiling of 84 drug transporters. Results Cell proliferation and differentiation depended on the used medium. The established epithelia expressed occludin, claudin-1, and E-cadherin under all conditions. Cells grown at the A-L interface formed more layers and exhibited a higher TEER and lower dextran and jacalin permeability than at the L-L interface, where cells morphologically exhibited a more differentiated phenotype. The expression of ABC and SLC transporters depended on culture duration and interface. Conclusions The RPMI 2650 cells form a polarized epithelium resembling nasal mucosa. However, different culture conditions have a significant effect on cell ultrastructure, barrier integrity, and gene expression, and should be considered when using this cell line as an in vitro model for drug permeability studies and screening of nasal drug candidates.
doi_str_mv 10.1007/s11095-014-1494-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1652412959</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1652412959</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-e67cefad9e062869bf7768556764e931fdf0763632b2feaac0c91f0569e03e2a3</originalsourceid><addsrcrecordid>eNp1kd9qFTEQxoNY7LH6AN5IwBtv1ibZ_Nlclm21hdNWpAXvlpzdiU3ZTdYkK9gn6mOawzkVEXqVMPOb75vhQ-gdJZ8oIeo4UUq0qAjlFeWaV-QFWlGh6koT_v0lWhHFeNUoTg_R65TuCSEN1fwVOmSCclHXaoUeb-4At3cmmj5DdA8mu-BxsDiX-vkyGY-vTDIjPptdKY2ufFsYR7x2HvC3r5cXmElB8K0fIOJTZy1E8Bm3y5iXWKSDH9xWM2HjB1zcXMTXc3bTk5cNsbTwyTzHMEdnMmDn8S-XY9hbX4YBxjfowJoxwdv9e4RuP5_dtOfV-vrLRXuyrnrOWa5Aqh6sGTQQyRqpN1Yp2QghleSga2oHS5SsZc02zIIxPek1tUTIMlADM_UR-rjTLev8XCDlbnKpLxcbD2FJHZWCccq00AX98B96H5boy3aF4lI3QnFSKLqj-hhSimC7cuVk4u-Okm4bY7eLsSsxdtsYu-3M-73ysplg-DvxlFsB2A5IpeV_QPzH-lnVPy7fqC8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1646985740</pqid></control><display><type>article</type><title>The Characterization of the Human Nasal Epithelial Cell Line RPMI 2650 Under Different Culture Conditions and Their Optimization for an Appropriate in vitro Nasal Model</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Kreft, Mateja Erdani ; Jerman, Urška Dragin ; Lasič, Eva ; Lanišnik Rižner, Tea ; Hevir-Kene, Neli ; Peternel, Luka ; Kristan, Katja</creator><creatorcontrib>Kreft, Mateja Erdani ; Jerman, Urška Dragin ; Lasič, Eva ; Lanišnik Rižner, Tea ; Hevir-Kene, Neli ; Peternel, Luka ; Kristan, Katja</creatorcontrib><description>ABSTRACT Purpose The further characterization of the cell line RPMI 2650 and the evaluation of different culture conditions for an in vitro model for nasal mucosa. Methods Cells were cultured in media MEM or A-MEM at air-liquid (A-L) or liquid-liquid (L-L) interfaces for 1 or 3 weeks. Different cryopreservation methods and cell culture techniques were evaluated with immunolabelling of junctional proteins, ultrastructural analysis using electron microscopy, transepithelial electrical resistance (TEER) measurements, permeation studies with dextran and jacalin, and gene expression profiling of 84 drug transporters. Results Cell proliferation and differentiation depended on the used medium. The established epithelia expressed occludin, claudin-1, and E-cadherin under all conditions. Cells grown at the A-L interface formed more layers and exhibited a higher TEER and lower dextran and jacalin permeability than at the L-L interface, where cells morphologically exhibited a more differentiated phenotype. The expression of ABC and SLC transporters depended on culture duration and interface. Conclusions The RPMI 2650 cells form a polarized epithelium resembling nasal mucosa. However, different culture conditions have a significant effect on cell ultrastructure, barrier integrity, and gene expression, and should be considered when using this cell line as an in vitro model for drug permeability studies and screening of nasal drug candidates.</description><identifier>ISSN: 0724-8741</identifier><identifier>EISSN: 1573-904X</identifier><identifier>DOI: 10.1007/s11095-014-1494-0</identifier><identifier>PMID: 25145337</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Biochemistry ; Biomedical and Life Sciences ; Biomedical Engineering and Bioengineering ; Biomedicine ; Cell culture ; Cell Culture Techniques - methods ; Cell Line ; Cell Proliferation - physiology ; Cell Survival - physiology ; Drug delivery systems ; Humans ; Medical Law ; Models, Biological ; Nasal Mucosa - cytology ; Nasal Mucosa - metabolism ; Nasal Mucosa - ultrastructure ; Nose ; Permeability ; Pharmaceutical sciences ; Pharmacology/Toxicology ; Pharmacy ; Research Paper</subject><ispartof>Pharmaceutical research, 2015-02, Vol.32 (2), p.665-679</ispartof><rights>Springer Science+Business Media New York 2014</rights><rights>Springer Science+Business Media New York 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-e67cefad9e062869bf7768556764e931fdf0763632b2feaac0c91f0569e03e2a3</citedby><cites>FETCH-LOGICAL-c442t-e67cefad9e062869bf7768556764e931fdf0763632b2feaac0c91f0569e03e2a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11095-014-1494-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11095-014-1494-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,778,782,27913,27914,41477,42546,51308</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25145337$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kreft, Mateja Erdani</creatorcontrib><creatorcontrib>Jerman, Urška Dragin</creatorcontrib><creatorcontrib>Lasič, Eva</creatorcontrib><creatorcontrib>Lanišnik Rižner, Tea</creatorcontrib><creatorcontrib>Hevir-Kene, Neli</creatorcontrib><creatorcontrib>Peternel, Luka</creatorcontrib><creatorcontrib>Kristan, Katja</creatorcontrib><title>The Characterization of the Human Nasal Epithelial Cell Line RPMI 2650 Under Different Culture Conditions and Their Optimization for an Appropriate in vitro Nasal Model</title><title>Pharmaceutical research</title><addtitle>Pharm Res</addtitle><addtitle>Pharm Res</addtitle><description>ABSTRACT Purpose The further characterization of the cell line RPMI 2650 and the evaluation of different culture conditions for an in vitro model for nasal mucosa. Methods Cells were cultured in media MEM or A-MEM at air-liquid (A-L) or liquid-liquid (L-L) interfaces for 1 or 3 weeks. Different cryopreservation methods and cell culture techniques were evaluated with immunolabelling of junctional proteins, ultrastructural analysis using electron microscopy, transepithelial electrical resistance (TEER) measurements, permeation studies with dextran and jacalin, and gene expression profiling of 84 drug transporters. Results Cell proliferation and differentiation depended on the used medium. The established epithelia expressed occludin, claudin-1, and E-cadherin under all conditions. Cells grown at the A-L interface formed more layers and exhibited a higher TEER and lower dextran and jacalin permeability than at the L-L interface, where cells morphologically exhibited a more differentiated phenotype. The expression of ABC and SLC transporters depended on culture duration and interface. Conclusions The RPMI 2650 cells form a polarized epithelium resembling nasal mucosa. However, different culture conditions have a significant effect on cell ultrastructure, barrier integrity, and gene expression, and should be considered when using this cell line as an in vitro model for drug permeability studies and screening of nasal drug candidates.</description><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedical Engineering and Bioengineering</subject><subject>Biomedicine</subject><subject>Cell culture</subject><subject>Cell Culture Techniques - methods</subject><subject>Cell Line</subject><subject>Cell Proliferation - physiology</subject><subject>Cell Survival - physiology</subject><subject>Drug delivery systems</subject><subject>Humans</subject><subject>Medical Law</subject><subject>Models, Biological</subject><subject>Nasal Mucosa - cytology</subject><subject>Nasal Mucosa - metabolism</subject><subject>Nasal Mucosa - ultrastructure</subject><subject>Nose</subject><subject>Permeability</subject><subject>Pharmaceutical sciences</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><subject>Research Paper</subject><issn>0724-8741</issn><issn>1573-904X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kd9qFTEQxoNY7LH6AN5IwBtv1ibZ_Nlclm21hdNWpAXvlpzdiU3ZTdYkK9gn6mOawzkVEXqVMPOb75vhQ-gdJZ8oIeo4UUq0qAjlFeWaV-QFWlGh6koT_v0lWhHFeNUoTg_R65TuCSEN1fwVOmSCclHXaoUeb-4At3cmmj5DdA8mu-BxsDiX-vkyGY-vTDIjPptdKY2ufFsYR7x2HvC3r5cXmElB8K0fIOJTZy1E8Bm3y5iXWKSDH9xWM2HjB1zcXMTXc3bTk5cNsbTwyTzHMEdnMmDn8S-XY9hbX4YBxjfowJoxwdv9e4RuP5_dtOfV-vrLRXuyrnrOWa5Aqh6sGTQQyRqpN1Yp2QghleSga2oHS5SsZc02zIIxPek1tUTIMlADM_UR-rjTLev8XCDlbnKpLxcbD2FJHZWCccq00AX98B96H5boy3aF4lI3QnFSKLqj-hhSimC7cuVk4u-Okm4bY7eLsSsxdtsYu-3M-73ysplg-DvxlFsB2A5IpeV_QPzH-lnVPy7fqC8</recordid><startdate>20150201</startdate><enddate>20150201</enddate><creator>Kreft, Mateja Erdani</creator><creator>Jerman, Urška Dragin</creator><creator>Lasič, Eva</creator><creator>Lanišnik Rižner, Tea</creator><creator>Hevir-Kene, Neli</creator><creator>Peternel, Luka</creator><creator>Kristan, Katja</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20150201</creationdate><title>The Characterization of the Human Nasal Epithelial Cell Line RPMI 2650 Under Different Culture Conditions and Their Optimization for an Appropriate in vitro Nasal Model</title><author>Kreft, Mateja Erdani ; Jerman, Urška Dragin ; Lasič, Eva ; Lanišnik Rižner, Tea ; Hevir-Kene, Neli ; Peternel, Luka ; Kristan, Katja</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-e67cefad9e062869bf7768556764e931fdf0763632b2feaac0c91f0569e03e2a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedical Engineering and Bioengineering</topic><topic>Biomedicine</topic><topic>Cell culture</topic><topic>Cell Culture Techniques - methods</topic><topic>Cell Line</topic><topic>Cell Proliferation - physiology</topic><topic>Cell Survival - physiology</topic><topic>Drug delivery systems</topic><topic>Humans</topic><topic>Medical Law</topic><topic>Models, Biological</topic><topic>Nasal Mucosa - cytology</topic><topic>Nasal Mucosa - metabolism</topic><topic>Nasal Mucosa - ultrastructure</topic><topic>Nose</topic><topic>Permeability</topic><topic>Pharmaceutical sciences</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><topic>Research Paper</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kreft, Mateja Erdani</creatorcontrib><creatorcontrib>Jerman, Urška Dragin</creatorcontrib><creatorcontrib>Lasič, Eva</creatorcontrib><creatorcontrib>Lanišnik Rižner, Tea</creatorcontrib><creatorcontrib>Hevir-Kene, Neli</creatorcontrib><creatorcontrib>Peternel, Luka</creatorcontrib><creatorcontrib>Kristan, Katja</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmaceutical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kreft, Mateja Erdani</au><au>Jerman, Urška Dragin</au><au>Lasič, Eva</au><au>Lanišnik Rižner, Tea</au><au>Hevir-Kene, Neli</au><au>Peternel, Luka</au><au>Kristan, Katja</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Characterization of the Human Nasal Epithelial Cell Line RPMI 2650 Under Different Culture Conditions and Their Optimization for an Appropriate in vitro Nasal Model</atitle><jtitle>Pharmaceutical research</jtitle><stitle>Pharm Res</stitle><addtitle>Pharm Res</addtitle><date>2015-02-01</date><risdate>2015</risdate><volume>32</volume><issue>2</issue><spage>665</spage><epage>679</epage><pages>665-679</pages><issn>0724-8741</issn><eissn>1573-904X</eissn><abstract>ABSTRACT Purpose The further characterization of the cell line RPMI 2650 and the evaluation of different culture conditions for an in vitro model for nasal mucosa. Methods Cells were cultured in media MEM or A-MEM at air-liquid (A-L) or liquid-liquid (L-L) interfaces for 1 or 3 weeks. Different cryopreservation methods and cell culture techniques were evaluated with immunolabelling of junctional proteins, ultrastructural analysis using electron microscopy, transepithelial electrical resistance (TEER) measurements, permeation studies with dextran and jacalin, and gene expression profiling of 84 drug transporters. Results Cell proliferation and differentiation depended on the used medium. The established epithelia expressed occludin, claudin-1, and E-cadherin under all conditions. Cells grown at the A-L interface formed more layers and exhibited a higher TEER and lower dextran and jacalin permeability than at the L-L interface, where cells morphologically exhibited a more differentiated phenotype. The expression of ABC and SLC transporters depended on culture duration and interface. Conclusions The RPMI 2650 cells form a polarized epithelium resembling nasal mucosa. However, different culture conditions have a significant effect on cell ultrastructure, barrier integrity, and gene expression, and should be considered when using this cell line as an in vitro model for drug permeability studies and screening of nasal drug candidates.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>25145337</pmid><doi>10.1007/s11095-014-1494-0</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0724-8741
ispartof Pharmaceutical research, 2015-02, Vol.32 (2), p.665-679
issn 0724-8741
1573-904X
language eng
recordid cdi_proquest_miscellaneous_1652412959
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Biochemistry
Biomedical and Life Sciences
Biomedical Engineering and Bioengineering
Biomedicine
Cell culture
Cell Culture Techniques - methods
Cell Line
Cell Proliferation - physiology
Cell Survival - physiology
Drug delivery systems
Humans
Medical Law
Models, Biological
Nasal Mucosa - cytology
Nasal Mucosa - metabolism
Nasal Mucosa - ultrastructure
Nose
Permeability
Pharmaceutical sciences
Pharmacology/Toxicology
Pharmacy
Research Paper
title The Characterization of the Human Nasal Epithelial Cell Line RPMI 2650 Under Different Culture Conditions and Their Optimization for an Appropriate in vitro Nasal Model
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T09%3A46%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Characterization%20of%20the%20Human%20Nasal%20Epithelial%20Cell%20Line%20RPMI%202650%20Under%20Different%20Culture%20Conditions%20and%20Their%20Optimization%20for%20an%20Appropriate%20in%20vitro%20Nasal%20Model&rft.jtitle=Pharmaceutical%20research&rft.au=Kreft,%20Mateja%20Erdani&rft.date=2015-02-01&rft.volume=32&rft.issue=2&rft.spage=665&rft.epage=679&rft.pages=665-679&rft.issn=0724-8741&rft.eissn=1573-904X&rft_id=info:doi/10.1007/s11095-014-1494-0&rft_dat=%3Cproquest_cross%3E1652412959%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1646985740&rft_id=info:pmid/25145337&rfr_iscdi=true